Issues in design, conduct, and conclusions of <scp>JAMA</scp>'s Hara et al.'s randomized clinical trial of spinal cord burst stimulation versus placebo stimulation on disability in patients with chronic radicular pain after lumbar spine surgery

Sam Eldabe reports consultancy fees from Medtronic, Mainstay Medical, Boston Scientific, and Abbott. He has received department research funding from the National Institute of Health Research, Medtronic and Nevro. Christopher Gilligan reports payment to his institution (for part of his salary) and stock-options received from Mainstay, personal fees from Mainstay, Saluda Medical, Persica, Eli Lilly, Iliad, research funded by Sollis, expert witness testimony fees, and serving as Editor in Chief of Pain Practice. Rod S. Taylor reports consultancy fees from Medtronic, Nevro and Saluda Medical. Kiran V. Patel is a consultant and speaker for Abbott. Rui V. Duarte is an employee of Saluda Medical. He has previously received consultancy fees from Boston Scientific, Mainstay Medical, Medtronic and Saluda Medical. Data sharing is not applicable to this article as no new data were created or analyzed in this study.